SCHEMBL386176

SCHEMBL386176

CCCC[CH]NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL386576 0.91
SCHEMBL16892581 0.88 TSHR (0.48)
SCHEMBL7462252 0.88 TSHR (0.48)
SCHEMBL385794 0.88 TSHR (0.48)
SCHEMBL8102175 0.88 TSHR (0.48)
SCHEMBL387549 0.88
SCHEMBL6672534 0.88 TSHR (0.48)
SCHEMBL386575 0.88 TSHR (0.48)
SCHEMBL5142056 0.88 TSHR (0.48)
SCHEMBL386565 0.88 TSHR (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 306 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117586262-A Nucleoside analogues and uses thereof 苏州旺山旺水生物医药有限公司 2024-02-23 CN claimed
CN-110256432-A Inhibit the polycyclic compound of MNK1 and MNK2 诺沃斯达药业有限公司 2019-09-20 CN claimed
WO-2019154133-A1 DIOXAZOLINE COMPOUND, PREPARATION METHOD THEREFOR, AND USES THEREOF 北京赛特明强医药科技有限公司 2019-08-15 WO claimed
CN-105175349-A Phenyl substituted triazine compounds adopted as EGFR inhibitor, and applications thereof NANJING SANHOME PHARMACEUTICAL CO LTD 2015-12-23 CN claimed
CN-104341416-A Protein tyrosine kinase inhibitor and application thereof NANJING SANHOME PHARMACEUTICAL CO LTD 2015-02-11 CN claimed
CN-102807868-B Preparation method of mixed (fluorescein isothiocyanate (FITC)/SiO2-CdTe quantum dots (QDs) )-SiO2 super structure encoding particles UNIV ZHEJIANG NORMAL 2014-01-15 CN claimed
CN-102807868-A Preparation method of mixed (fluorescein isothiocyanate (FITC)/SiO2-CdTe quantum dots (QDs) )-SiO2 super structure encoding particles UNIV ZHEJIANG NORMAL 2012-12-05 CN claimed
CN-102524752-A Method for extracting volatile components from coprinus comatus BEIJING POLYTECHNIC 2012-07-04 CN claimed
EP-1511734-B1 COMPOUNDS, COMPOSITIONS, AND METHODS CYTOKINETICS INC (US) 2010-06-23 EP claimed
US-20100048539-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2010-02-25 US claimed
WO-2005013888-A2 COMPOUNDS, COMPOSITIONS AND METHODS CYTOKINETICS, INC. (US) 2005-02-17 WO claimed
WO-2004103282-A2 COMPOUNDS, COMPOSITIONS AND METHODS CYTOKINETICS, INC. (US) 2004-12-02 WO claimed
US-6821965-B1 IMPORTANT IN DISEASE OR MEDICAL CONDITIONS SUCH AS INFLAMMATION AND IMMUNOREGULATION ASTERZENECA AB (SE) 2004-11-23 US claimed
WO-2004091547-A2 COMPOUNDS, COMPOSITIONS, AND METHODS CYTOKINETICS, INC (US) 2004-10-28 WO claimed
WO-2004092164-A1 CYCLIC AMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF INFLAMMATION-RELATED DISORDERS MEDIATED BY BRADYKININ AMGEN, INC. (US) 2004-10-28 WO claimed
WO-2004092116-A1 BICYCLIC COMPOUNDS HAVING BRADYKININ RECEPTORS AFFINITY AND PHARMACEUTICAL COMPOSITIONS THEREOF AMGEN, INC. (US) 2004-10-28 WO claimed
WO-2004032879-A2 COMPOUNDS, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2004-04-22 WO claimed
EP-1102743-A1 AMIDE DERIVATIVES WHICH ARE USEFUL AS CYTOKINE INHIBITORS AstraZeneca AB (SE) 2001-05-30 EP claimed
WO-2000007980-A1 AMIDE DERIVATIVES WHICH ARE USEFUL AS CYTOKINE INHIBITORS ASTRAZENECA AB (SE) 2000-02-17 WO claimed
EP-0281731-A2 1-Aminomethyl-3-aryl-4-cyano-pyrroles BAYER AG (DE) 1988-09-14 EP claimed